Kiniksa Pharmaceuticals International Plc (KNSA)
58.60
+1.67
(+2.93%)
USD |
NASDAQ |
May 08, 16:00
58.54
-0.06
(-0.10%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.2741 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.2496 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| United Therapeutics Corp. | 5.824 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.59M |
| Revenue (Quarterly) | 214.27M |
| Total Expenses (Quarterly) | 191.67M |
| Enterprise Value | 4.049B |
| Gross Profit Margin (Quarterly) | 54.95% |
| Profit Margin (Quarterly) | 10.54% |
| Earnings Yield | 1.55% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | 1.548 |